CLINICAL TRIALS – CALL AIFA 2018 FOR INDEPENDENT RESEARCH ON MEDICINAL PRODUCTS

The Italian Medicines Agency (AIFA) has recently published a call for independent research focused on three thematic areas considered of…

READ

SCIENTIFIC SERVICE IN ITALY: FROM THE PAST TO THE FUTURE

Since 1  July  1993 with the Legislative decree 30 December 1992, n. 541 and after its abolition following the entry…

READ

IMPACTS AND NEWS OF THE FINANCIAL LAW 2019

Within the publications of the annual Financial Law, some new depositions have been set for the healthcare system and the…

READ

EUROPEAN REGULATION 2017/745 – NEW DEFINITION OF INCIDENT AND UPDATES ON VIGILANCE AND POST-MARKET SURVEILLANCE ACTIVITIES

The new European Regulation 2017/745 on medical devices will introduce new activities and a new approach in the management of…

READ

THE MAIN INNOVATIONS OF THE EUROPEAN REGULATION 745/2017

In about one year the new European regulation on medical devices, European Regulation 745/2017, will be reality and the new…

READ

EUROPEAN REGULATION 2017/745 – Clinical evaluation: new requirements for equivalence demonstration

The European regulation 2017/745, that will entry into force in May 2020, introduces several new elements with an impact on…

READ

“Pharma disclosure”: EFPIA’s Code on Transfers of Value

Starting from 2016, European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies made public the details of payments and…

READ

MEDICAL DEVICES – European Regulation 2017/745 – What happens to CE certificates obtained in compliance with the “old directive” 93/42/EEC?

The entry into force of the new regulation is now close. From 26 May 2020 it will no longer be…

READ

The management of the clinical trial in Italy after the Brexit

  On 29 March 2017 The United Kingdom notified its intention to withdraw from the European Union.  Thus, unless there…

READ

Optimising Orphan Drug Development in the EU

  The legislative framework on orphan medicinal products aims at stimulating research and development of medicinal products for rare diseases…

READ